Swiss National Bank’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.76M Hold
187,400
﹤0.01% 1871
2025
Q1
$1.33M Sell
187,400
-2,300
-1% -$16.4K ﹤0.01% 1994
2024
Q4
$2.21M Buy
189,700
+10,700
+6% +$125K ﹤0.01% 1790
2024
Q3
$3.68M Sell
179,000
-1,300
-0.7% -$26.7K ﹤0.01% 1501
2024
Q2
$4.04M Buy
180,300
+12,400
+7% +$278K ﹤0.01% 1400
2024
Q1
$4.62M Buy
167,900
+2,200
+1% +$60.5K ﹤0.01% 1347
2023
Q4
$5.05M Sell
165,700
-8,700
-5% -$265K ﹤0.01% 1292
2023
Q3
$5.51M Buy
174,400
+1,900
+1% +$60.1K ﹤0.01% 1222
2023
Q2
$7.03M Buy
172,500
+19,700
+13% +$803K ﹤0.01% 1104
2023
Q1
$5.69M Sell
152,800
-12,400
-8% -$462K ﹤0.01% 1185
2022
Q4
$5.76M Buy
165,200
+3,300
+2% +$115K ﹤0.01% 1229
2022
Q3
$9.06M Buy
161,900
+4,100
+3% +$229K 0.01% 940
2022
Q2
$8.17M Sell
157,800
-600
-0.4% -$31.1K 0.01% 1026
2022
Q1
$11.5M Buy
158,400
+12,900
+9% +$937K 0.01% 938
2021
Q4
$17.2M Buy
145,500
+9,900
+7% +$1.17M 0.01% 740
2021
Q3
$18.2M Buy
135,600
+1,200
+0.9% +$161K 0.01% 710
2021
Q2
$21.8M Buy
134,400
+26,400
+24% +$4.27M 0.01% 678
2021
Q1
$8.67M Buy
108,000
+1,800
+2% +$144K 0.01% 1086
2020
Q4
$5.78M Buy
106,200
+3,100
+3% +$169K ﹤0.01% 1275
2020
Q3
$2.05M Buy
103,100
+1,500
+1% +$29.8K ﹤0.01% 1709
2020
Q2
$2.14M Buy
101,600
+36,100
+55% +$759K ﹤0.01% 1677
2020
Q1
$801K Hold
65,500
﹤0.01% 1957
2019
Q4
$961K Buy
65,500
+5,500
+9% +$80.7K ﹤0.01% 2163
2019
Q3
$801K Buy
60,000
+1,100
+2% +$14.7K ﹤0.01% 2168
2019
Q2
$964K Buy
58,900
+16,400
+39% +$268K ﹤0.01% 2131
2019
Q1
$726K Hold
42,500
﹤0.01% 2243
2018
Q4
$580K Hold
42,500
﹤0.01% 2294
2018
Q3
$1.22M Hold
42,500
﹤0.01% 2034
2018
Q2
$1.16M Buy
42,500
+4,300
+11% +$118K ﹤0.01% 2072
2018
Q1
$806K Sell
38,200
-1,500
-4% -$31.6K ﹤0.01% 2196
2017
Q4
$763K Buy
39,700
+19,000
+92% +$365K ﹤0.01% 2236
2017
Q3
$514K Hold
20,700
﹤0.01% 2374
2017
Q2
$331K Hold
20,700
﹤0.01% 2508
2017
Q1
$292K Hold
20,700
﹤0.01% 2489
2016
Q4
$271K Buy
+20,700
New +$271K ﹤0.01% 2525